ProtoPulse · CNAS therapeutic protocols
Data updated 19 Oct 2026, 22:37 · printed from ProtoPulse

APALUTAMIDUM

Active substance (INN) · ATC L02BB05 · 2 products authorised in Romania
◀ Back
1

Protocols it appears in

As a medicine of the protocol (in the title) or only mentioned in the text

CodeProtocolStatusRoleSublistGP
L02BB05 APALUTAMIDUM In force medicine of the protocol C2-P3 YES
D11AH-L04AA DERMATITA ATOPICĂ - AGENŢI BIOLOGICI: DUPILUMABUM**1Ω ȘI INHIBITORI DE JAK: BARICITINIBUM**1Ω, UPADACITINIBUM (15 mg, 30 mg)**1Ω, ABROCITINIBUM**1Ω In force mentioned in the text C1-G31G NO
L02BB06 DAROLUTAMIDUM In force mentioned in the text C2-P3 YES
2

History: entries into and exits from protocols

MonthTypeCodeProtocolLevel
January 2026Medicine added D11AH-L04AADERMATITA ATOPICĂ - AGENŢI BIOLOGICI: DUPILUMABUM**1Ω ȘI INHIBITORI DE JAK: BARICITINIBUM**1Ω, UPADACITINIBUM (15 mg, 30 mg)**1Ω, ABROCITINI mentioned in the text
3

Authorised brand products (ANMDM)

The Romanian register of medicines for human use, updated daily

Brand nameFormStrengthHolderATCRx
ERLEADA 240 mgCOMPR. FILM.240mgJANSSEN-CILAG INTERNATIONAL NV - BELGIAL02BB05PR
ERLEADA 60 mgCOMPR. FILM.60mgJANSSEN-CILAG INTERNATIONAL NV - BELGIAL02BB05PR

Data extracted automatically from the documents published by CNAS (cnas.ro/protocoale-terapeutice) and from the ANMDM medicines register. For information only; the official text (the Ministry of Health / CNAS orders published in the Official Gazette) prevails. Protocol names and texts are shown in Romanian, as published.